Results 241 to 250 of about 63,834 (278)
Polycystic ovarian syndrome awareness among females in Palestine: a cross‑sectional study. [PDF]
Shrateh ON +16 more
europepmc +1 more source
Depression and anxiety among women with polycystic ovarian syndrome in low- and middle-income countries: a systematic review and meta-analysis. [PDF]
Atinga A +16 more
europepmc +1 more source
The Effects of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists on Polycystic Ovarian Syndrome: A Scoping Review. [PDF]
Hudanich M +3 more
europepmc +1 more source
The promoter T-413A variant and elevated enzyme levels of heme oxygenase-1 associated with an increased risk of polycystic ovarian syndrome. [PDF]
Wang Q +6 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Medical Clinics of North America, 2023
Polycystic ovarian syndrome (PCOS) is a complex, familial, polygenetic metabolic condition. The Rotterdam criteria are commonly used to diagnose PCOS. Lifestyle changes are the first-line treatment of PCOS. Treatment options for menstrual irregularities and hirsutism are based on the clinical goals and preferences of the patient.
Sneha, Shrivastava +1 more
+5 more sources
Polycystic ovarian syndrome (PCOS) is a complex, familial, polygenetic metabolic condition. The Rotterdam criteria are commonly used to diagnose PCOS. Lifestyle changes are the first-line treatment of PCOS. Treatment options for menstrual irregularities and hirsutism are based on the clinical goals and preferences of the patient.
Sneha, Shrivastava +1 more
+5 more sources
Medical Clinics of North America, 2015
Women with PCOS present with signs of chronic anovulation, hyperandrogenism, and metabolic abnormalities. The NIH recently embraced the Rotterdam criteria to broadly identify all the phenotypes of PCOS. Women with PCOS are often obese with insulin resistance and hence have an increased susceptibility to glucose intolerance and type 2 diabetes.
Jason, Klein +2 more
+6 more sources
Women with PCOS present with signs of chronic anovulation, hyperandrogenism, and metabolic abnormalities. The NIH recently embraced the Rotterdam criteria to broadly identify all the phenotypes of PCOS. Women with PCOS are often obese with insulin resistance and hence have an increased susceptibility to glucose intolerance and type 2 diabetes.
Jason, Klein +2 more
+6 more sources
InnovAiT: Education and inspiration for general practice, 2010
Polycystic ovarian syndrome (PCOS) was first recognized by Drs Stein and Leventhal in 1935. It is a common but poorly understood complex endocrine disorder clinically associated with infertility, hyperandrogenism and oligomenorrhoea. The UK prevalence is around 6–7%.
Mala Dharmalingam, Himanshu M
+8 more sources
Polycystic ovarian syndrome (PCOS) was first recognized by Drs Stein and Leventhal in 1935. It is a common but poorly understood complex endocrine disorder clinically associated with infertility, hyperandrogenism and oligomenorrhoea. The UK prevalence is around 6–7%.
Mala Dharmalingam, Himanshu M
+8 more sources
Journal of the CardioMetabolic Syndrome, 2006
Polycystic ovarian syndrome (PCOS) is the most common reproductive endocrinopathy of women during their childbearing years. A significant degree of controversy exists regarding the etiology of this syndrome, but there is a growing consensus that the key features include insulin resistance, androgen excess, and abnormal gonadotropin dynamics.
Khurshid A, Khan +2 more
openaire +4 more sources
Polycystic ovarian syndrome (PCOS) is the most common reproductive endocrinopathy of women during their childbearing years. A significant degree of controversy exists regarding the etiology of this syndrome, but there is a growing consensus that the key features include insulin resistance, androgen excess, and abnormal gonadotropin dynamics.
Khurshid A, Khan +2 more
openaire +4 more sources

